WS MANAGEMENT LLLP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
WS MANAGEMENT LLLP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$395,000
+18.3%
80,6500.0%0.04%
+33.3%
Q2 2022$334,000
-28.8%
80,6500.0%0.03%
+17.4%
Q1 2022$469,000
-22.5%
80,6500.0%0.02%
-52.1%
Q4 2021$605,000
-16.8%
80,6500.0%0.05%
-37.7%
Q3 2021$727,000
-24.7%
80,6500.0%0.08%
-18.9%
Q2 2021$965,000
-4.5%
80,6500.0%0.10%
-9.5%
Q1 2021$1,011,000
-23.6%
80,650
-4.9%
0.10%
-23.4%
Q4 2020$1,323,000
+65.2%
84,8110.0%0.14%
+59.3%
Q3 2020$801,000
+5.4%
84,8110.0%0.09%
-7.5%
Q2 2020$760,000
+20.1%
84,811
-14.6%
0.09%
+34.8%
Q1 2020$633,000
-27.5%
99,320
-4.8%
0.07%
-8.0%
Q4 2019$873,000
-7.5%
104,2880.0%0.08%
+1.4%
Q3 2019$944,000
-24.3%
104,288
-9.9%
0.07%
-8.6%
Q2 2019$1,247,000
+1.1%
115,739
-10.5%
0.08%
+8.0%
Q1 2019$1,234,000
-26.8%
129,372
-11.8%
0.08%
-8.5%
Q4 2018$1,685,000
-59.1%
146,740
-39.6%
0.08%
-39.3%
Q3 2018$4,119,000
+19.4%
243,0000.0%0.14%
+39.2%
Q2 2018$3,451,000243,0000.10%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders